| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/25/2007 | WO2007012075A2 Preparation of montelukast |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009250A1 Renin inhibitors |
| 01/25/2007 | WO2007009227A1 Hepatitis c inhibitor peptide analogs |
| 01/25/2007 | WO2006130080A3 Quinoline derivatives as nk3 anatgonists |
| 01/25/2007 | WO2005090336A8 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands |
| 01/25/2007 | US20070021612 Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070020182 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors |
| 01/25/2007 | CA2615048A1 Renin inhibitors |
| 01/24/2007 | EP1746092A1 Compounds and methods for treatment of amyloid-B-peptide related disorders |
| 01/24/2007 | EP1745022A1 Histone deacetylase inhibitor prodrugs |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | CN1902322A Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902179A Methods and compositions for selectin inhibition |
| 01/24/2007 | CN1902160A Non-symmetrical gelling agent |
| 01/24/2007 | CN1900075A Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 01/24/2007 | CN1900064A Synthesis and application of 6-(2-methoxy phenoxy)-1,4-dihydrogen-4-oxo-3-ethyl quinolinecarboxylate |
| 01/24/2007 | CN1296369C Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 01/24/2007 | CN1296358C Method for composing ethoxy quinoline |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates |
| 01/23/2007 | US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166472 Adding a reducible redox-active metal to a first and a second target protein sample of an auto-oxidizing kynurenine pathway metabolite; incubating to allow cross-linking of target protein, comparing the amounnt of target protein cross-linking |
| 01/23/2007 | US7166240 Luminescent efficiency and a long luminescent life |
| 01/18/2007 | WO2007007132A1 Aripiprazole salts |
| 01/18/2007 | WO2007006734A1 New benzoheterocyclylethylbenzamide derivatives |
| 01/18/2007 | US20070015798 Efficient and stereoselective process for large scale synthesis of (3R)-3-(2,3-dihydrobenzofuran-5-yl)-1,2,3,4-tetrahydropyrrolo[3,4-b]quinolin-9-one derivatives |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742918A1 Lxr receptor modulators |
| 01/17/2007 | EP1742902A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
| 01/17/2007 | CN1898227A Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 01/17/2007 | CN1898211A Crystal form of quinoline compound and process for its production |
| 01/17/2007 | CN1896063A Stabilized high-melt-point alipizo crystal and its preparation |
| 01/17/2007 | CN1295218C Olefin monomers of single-functional group 8-hydroxyquinoline metal complex and their preparation process and application |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/16/2007 | US7163942 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/11/2007 | WO2007005965A1 Purification of montelukast |
| 01/11/2007 | WO2007005887A2 Androgen receptor modulator compounds, compositions and uses thereof |
| 01/11/2007 | WO2007005462A1 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
| 01/11/2007 | WO2007004237A2 A process for the preparation of montelukast |
| 01/11/2007 | WO2007004061A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | WO2007003308A1 Substituted quinolones ii |
| 01/11/2007 | US20070010676 Stereospecific enrichment of heterocyclic enantiomers |
| 01/11/2007 | US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/11/2007 | US20070010552 Fluorinated heterocyclic compounds and methods of synthesis |
| 01/11/2007 | US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 01/11/2007 | US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 01/11/2007 | CA2613053A1 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| 01/11/2007 | CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | CA2611688A1 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 01/11/2007 | CA2608369A1 Purification of montelukast |
| 01/11/2007 | CA2605128A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/10/2007 | EP1740580A2 Crystalline 2-amino-3-cyanoquinoline derivatives , process of their preparation and pharmaceutical compositions containing them |
| 01/10/2007 | EP1740557A1 Urea derivatives as antagonists of the vanilloid receptor (vr1) |
| 01/10/2007 | EP1740547A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740546A2 Process for making montelukast and intermediates therefor |
| 01/10/2007 | EP1740545A1 Process for making montelukast and intermediates therefor |
| 01/10/2007 | EP1740532A2 Hydrazide-containing cftr inhibitor compounds and uses thereof |
| 01/10/2007 | EP1262476B1 Processes for preparing quinoline derivatives and intermediates thereof |
| 01/10/2007 | EP1066259B1 Biocidal benzylbiphenyl derivatives |
| 01/10/2007 | CN1894267A Monocyclopentadienyl complexes |
| 01/10/2007 | CN1894216A Novel process for preparing 3-fluoroquinolines |
| 01/10/2007 | CN1893957A Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 01/10/2007 | CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1293809C Fungicide mixture |
| 01/09/2007 | US7161172 Using fluorine substituted 2-phenylpyridine, phenylpyrimidine or phenylquinoline compound |
| 01/09/2007 | US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
| 01/09/2007 | CA2394720C Cyanomethylene compounds and fungicidal compositions |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | WO2007000436A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000435A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000434A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2006108714A3 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | US20070004774 Cept inhibitors and metabolites thereof |
| 01/04/2007 | US20070004773 Amorphous salt of 4-(3-chiloro-4-(cycloproplylaminocarbonyl)aminophenoxy)-7-method-6-quinolinecarboxamide and process for preparing the same |